  A plethora of machine learning methods have been applied to imaging data,
enabling the construction of clinically relevant imaging signatures of
neurological and neuropsychiatric diseases. Oftentimes, such methods don't
explicitly model the heterogeneity of disease effects, or approach it via
nonlinear models that are not interpretable. Moreover, unsupervised methods may
parse heterogeneity that is driven by nuisance confounding factors that affect
brain structure or function, rather than heterogeneity relevant to a pathology
of interest. On the other hand, semi-supervised clustering methods seek to
derive a dichotomous subtype membership, ignoring the truth that disease
heterogeneity spatially and temporally extends along a continuum. To address
the aforementioned limitations, herein, we propose a novel method, termed
Surreal-GAN (Semi-SUpeRvised ReprEsentAtion Learning via GAN). Using
cross-sectional imaging data, Surreal-GAN dissects underlying disease-related
heterogeneity under the principle of semi-supervised clustering (cluster
mappings from normal control to patient), proposes a continuously dimensional
representation, and infers the disease severity of patients at individual level
along each dimension. The model first learns a transformation function from
normal control (CN) domain to the patient (PT) domain with latent variables
controlling transformation directions. An inverse mapping function together
with regularization on function continuity, pattern orthogonality and
monotonicity was also imposed to make sure that the transformation function
captures necessarily meaningful imaging patterns with clinical significance. We
first validated the model through extensive semi-synthetic experiments, and
then demonstrate its potential in capturing biologically plausible imaging
patterns in Alzheimer's disease (AD).
